Abstract

Interventions to reduce workplace sitting time have been shown to be effective, but little is known about their cost-effectiveness. This study assessed the economic credentials of a workplace-delivered intervention to reduce sitting time in desk-based workers. Within-trial cost-efficacy analysis and long-term cost-effectiveness analysis (CEA) modelled for the Australian population were performed. In total, 231 desk-based workers aged 24-65 years of one organisation were recruited in a clustered randomized controlled trial. A multicomponent workplace-delivered intervention (including organizational, environmental [sit-stand workstations], and individual [health coaching] intervention elements) was compared to usual practice. Total device-measured workplace sitting time (primary), Body Mass Index (BMI: kg/m2), self-reported health-related quality of life (measured by Assessment of Quality of Life-8D), and absenteeism were measured at 12 months. Compared to usual practice, the intervention was associated with greater cost (AUD431/person) and benefits in terms of reduced workplace sitting time (-46.8 mins/8-h workday, 95% confidence interval: -69.9 to -23.7) and increased workplace standing time (42.2 mins/8-h workday, 23.8 to 60.6). However, there were no significant benefits for BMI (0.148 kg/m2 [-1.407 to 1.703]), AQoL-8D (-0.006 [-0.074 to 0.063]) or absenteeism (2.12 days [-2.01 to 6.26]). The incremental cost-efficacy ratios ranged from AUD9.94 cost/minute reduction in workplace sitting time to AUD13.37/minute reduction in overall sitting time. The intervention contributed to higher life year gains (LY) (0.01 [0.009 to 0.011]), higher health-adjusted life year gains (HALY) (0.012 [0.0105 to 0.0135]), and higher net costs (AUD344 [$331 to $358]), with corresponding incremental cost effectiveness ratios of AUD34,443/LY and $28,703/HALY. CEA results were sensitive to assumptions surrounding intervention-effect decay rate and discount rate. The intervention was cost-effective over the lifetime of the cohort when scaled up to the national workforce. It provides important evidence for policy makers and workplaces regarding allocation of resources to reduce workplace sitting.

Highlights

  • PMU30 THE IMPACT OF THE COST OF EXISTING TREATMENT ON THE RESULTS OF COST-EFFECTIVENESS ANALYSIS STUDIES FOR JAPAN LoPresti M1, Mazumder D2, Bhandari H3, Ranjan S3, Smulders M4 1Junicon K.K., Tokyo, Japan, 2SmartAnalyst, Gurgaon, India, 3SmartAnalyst India Pvt

  • These classified Drug Related Problems (DRPs) were judged for the potential impacts to patients if there were no intervention made by the pharmacist and these potential impacts were calculated into cost avoidance

  • The result of one-way sensitivity analysis demonstrated the potential impact in cost of medication and laboratory-test which ranged the hospital cost saving from 3,076.62 USD to 5,581.31 USD

Read more

Summary

Introduction

PMU30 THE IMPACT OF THE COST OF EXISTING TREATMENT ON THE RESULTS OF COST-EFFECTIVENESS ANALYSIS STUDIES FOR JAPAN LoPresti M1, Mazumder D2, Bhandari H3, Ranjan S3, Smulders M4 1Junicon K.K., Tokyo, Japan, 2SmartAnalyst, Gurgaon, India, 3SmartAnalyst India Pvt. RESULTS: 89% of respondents confirmed that clinical improvement of using the above digital health intervention to support clinical decision-making would be moderate to major and that they would be willing to pay for such interventions, providing cost offsets (e.g. reduced hospitalisations) and/or improved efficiency in staff utilisation could be demonstrated.

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.